NM_001011658.4:c.191_192delTG
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001011658.4(TRAPPC2):c.191_192delTG(p.Val64GlyfsTer24) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001011658.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- ciliopathyInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- Joubert syndrome 10Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- orofaciodigital syndrome IInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
- retinitis pigmentosa 23Inheritance: XL Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- retinitis pigmentosaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- orofaciodigital syndrome type 6Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Simpson-Golabi-Behmel syndrome type 2Inheritance: XL Classification: LIMITED Submitted by: G2P
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001011658.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TRAPPC2 | NM_001011658.4 | MANE Select | c.191_192delTG | p.Val64GlyfsTer24 | frameshift | Exon 4 of 6 | NP_001011658.1 | ||
| TRAPPC2 | NM_001128835.3 | c.293_294delTG | p.Val98GlyfsTer24 | frameshift | Exon 4 of 6 | NP_001122307.2 | |||
| TRAPPC2 | NM_014563.6 | c.191_192delTG | p.Val64GlyfsTer24 | frameshift | Exon 3 of 5 | NP_055378.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TRAPPC2 | ENST00000380579.6 | TSL:1 MANE Select | c.191_192delTG | p.Val64GlyfsTer24 | frameshift | Exon 4 of 6 | ENSP00000369953.1 | ||
| TRAPPC2 | ENST00000683983.1 | c.293_294delTG | p.Val98GlyfsTer24 | frameshift | Exon 4 of 6 | ENSP00000507474.1 | |||
| TRAPPC2 | ENST00000359680.9 | TSL:1 | c.191_192delTG | p.Val64GlyfsTer24 | frameshift | Exon 3 of 5 | ENSP00000352708.5 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
not provided Pathogenic:2
For these reasons, this variant has been classified as Pathogenic. This variant has been observed in individual(s) with spondyloepiphyseal dysplasia tarda (PMID: 10431248). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Val64Glyfs*24) in the TRAPPC2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TRAPPC2 are known to be pathogenic (PMID: 11349230).
TRAPPC2: PVS1, PM2, PS4:Moderate
Spondyloepiphyseal dysplasia tarda Pathogenic:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at